rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert J. Hugin

Director

Company insider

Files Form 4 as: Director, Chubb; Director, Biohaven; Director, Biohaven Pharmaceutical Holding Co; Director, Allergan; Director, Medicines Co /de; Chairman and CEO, Celgene Corp /de/; Director, Danaher; Director, Coley Pharmaceutical Group.

Every Form 4 they filed

In numbers

Trades disclosed
377
Buys
1
Sells
13
Bought
$527K
Sold
$168.8M
Companies
8
Companies where not an officer
7
First trade
23 Dec 2005
Last trade
21 May 2026
Last filed
26 May 2026

Companies traded

Where they are an officer
Celgene Corp /de/Director, Officer · last 30 Oct 20171 buy · 13 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CB ChubbDirector · Insurance · last 21 May 20260 buys · 0 sells
BHVN BiohavenDirector · Biotechnology · last 28 Apr 20260 buys · 0 sells
Biohaven Pharmaceutical Holding CoDirector · last 3 Oct 20220 buys · 0 sells
AllerganDirector · last 8 May 20200 buys · 0 sells
Medicines Co /deDirector · last 9 Nov 20170 buys · 0 sells
DHR DanaherDirector · Life-science tools · last 15 May 20170 buys · 0 sells
Coley Pharmaceutical GroupDirector · last 4 Jan 20080 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 26 May 2026CB ChubbInsuranceSEC FORM 4 Code A—1,135filing
21 May 2026filed 26 May 2026CB ChubbInsuranceSEC FORM 4 Code A—1,135filing
28 Apr 2026filed 30 Apr 2026BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—68,693 at $0.00filing
28 Apr 2026filed 30 Apr 2026BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—68,693 at $0.00filing
15 May 2025filed 16 May 2025CB ChubbInsuranceSEC FORM 4 Code A—1,284filing
5 May 2025filed 7 May 2025BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—31,716 at $0.00filing
16 May 2024filed 17 May 2024CB ChubbInsuranceSEC FORM 4 Code A—1,227filing
30 Apr 2024filed 2 May 2024BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—16,592 at $0.00filing
17 May 2023filed 19 May 2023CB ChubbInsuranceSEC FORM 4 Code A—1,634filing
2 May 2023filed 4 May 2023BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—52,906 at $0.00filing
3 Oct 2022filed 12 Oct 2022BHVN BiohavenBiotechnologySEC FORM 4 Code F$97K12,959 at $7.50filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code J—4,119filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code J—5,998filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code J—9,474filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code M—4,119 at $0.00filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code M—5,998 at $0.00filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code M—9,474 at $0.00filing
3 Oct 2022filed 5 Oct 2022BHVN Biohavenoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
3 Oct 2022filed 5 Oct 2022BHVN BiohavenBiotechnologySEC FORM 4 Code J—1,450 at $0.00filing
3 Oct 2022filed 5 Oct 2022BHVN BiohavenBiotechnologySEC FORM 4 Code J—1,708 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed14

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.